Clinical Trials
12
Active:1
Completed:3
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
phase_2_3
3 (30.0%)Phase 3
3 (30.0%)Phase 1
2 (20.0%)phase_1_2
1 (10.0%)Phase 2
1 (10.0%)Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Natureceuticals Sdn Bhd
- Target Recruit Count
- 100
- Registration Number
- NCT04552600
- Locations
- 🇮🇳
Fifepoint Multispeciality Hospital Pvt. Ltd., Pune, Maharashtra, India
Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia
Phase 2
Completed
- Conditions
- AstheniaCancer
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Natureceuticals Sdn Bhd
- Target Recruit Count
- 110
- Registration Number
- NCT04546607
- Locations
- 🇮🇳
Notrox Research Pvt Ltd, Bangalore, Karnataka, India
To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Natureceuticals Sdn Bhd
- Target Recruit Count
- 10
- Registration Number
- NCT04542447
- Locations
- 🇮🇳
Navin Hospital, Ghaziabad, Uttar Pradesh, India
News
No news found